当前位置:首页 - 行情中心 - 天臣医疗(688013) - 财务分析 - 现金流量表

天臣医疗

(688013)

  

流通市值:42.96亿  总市值:42.96亿
流通股本:8115.56万   总股本:8115.56万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金260,680,120.73162,653,794.3474,632,957.61287,753,394.5
  收到的税费返还4,572,751.964,572,751.96-4,754,268.11
  收到其他与经营活动有关的现金2,144,866.57796,176.11212,976.635,771,719.23
  经营活动现金流入小计267,397,739.26168,022,722.4174,845,934.24298,279,381.84
  购买商品、接受劳务支付的现金98,807,010.762,577,830.6627,888,650.23122,823,492.93
  支付给职工以及为职工支付的现金57,915,528.1940,136,194.8822,794,451.7864,406,593.22
  支付的各项税费13,483,766.217,017,832.121,867,725.5219,215,789.63
  支付其他与经营活动有关的现金33,407,274.321,312,582.889,164,805.4138,424,534.36
  经营活动现金流出小计203,613,579.4131,044,440.5461,715,632.94244,870,410.14
  经营活动产生的现金流量净额63,784,159.8636,978,281.8713,130,301.353,408,971.7
二、投资活动产生的现金流量:
  收回投资收到的现金448,755,911.8435,055,911.8239,854,418.8996,582,579.7
  取得投资收益收到的现金2,593,066.482,346,670.951,316,608.36,565,162.47
  收到的其他与投资活动有关的现金350,000200,000200,00010,490,000
  投资活动现金流入小计451,698,978.28437,602,582.75241,371,027.11,013,637,742.17
  购建固定资产、无形资产和其他长期资产支付的现金53,182,710.2744,898,773.0615,298,553.2541,940,427.32
  投资支付的现金390,605,702.98342,690,203.7253,062,6731,116,951,818.5
  支付其他与投资活动有关的现金9,225,0009,190,000140,0001,950,000
  投资活动现金流出小计453,013,413.25396,778,976.76268,501,226.251,160,842,245.82
  投资活动产生的现金流量净额-1,314,434.9740,823,605.99-27,130,199.15-147,204,503.65
三、筹资活动产生的现金流量:
  吸收投资收到的现金22,715,013.322,715,013.314,744,00027,156,109.85
  取得借款收到的现金47,022,965.6232,972,965.6220,079,920.9749,723,908.69
  筹资活动现金流入小计69,737,978.9255,687,978.9234,823,920.9776,880,018.54
  偿还债务支付的现金25,853,591.6222,853,497.62-49,723,908.69
  分配股利、利润或偿付利息支付的现金81,119,657.1681,084,834.4939,587,64738,305,042.53
  支付其他与筹资活动有关的现金1,901,339.311,655,010.92326,645.6442,508,222.36
  筹资活动现金流出小计108,874,588.09105,593,343.0339,914,292.64130,537,173.58
  筹资活动产生的现金流量净额-39,136,609.17-49,905,364.11-5,090,371.67-53,657,155.04
四、汇率变动对现金及现金等价物的影响7,266,846.556,642,598.51,550,362.0945,016.56
五、现金及现金等价物净增加额30,599,962.2734,539,122.25-17,539,907.43-147,407,670.43
  加:期初现金及现金等价物余额64,125,887.5864,125,887.5864,125,887.58211,533,558.01
  期末现金及现金等价物余额94,725,849.8598,665,009.8346,585,980.1564,125,887.58
补充资料:
  净利润-48,211,574.09-51,894,845.59
  资产减值准备-281,134.21-338,423.76
  固定资产和投资性房地产折旧-4,985,599.56-9,117,902.79
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-4,985,599.56-9,117,902.79
  无形资产摊销-299,355.6-524,968.35
  长期待摊费用摊销-59,593.67-153,541.52
  处置固定资产、无形资产和其他长期资产的损失--686.5--
  固定资产报废损失-10,313.41-1,051.87
  公允价值变动损失--1,669,079.24-1,891,985.38
  财务费用--462,899.01-233,643.11
  投资损失--2,346,670.95--6,565,162.47
  递延所得税--806,104.87-1,786,650.8
  其中:递延所得税资产减少--850,979.4-1,336,417.52
    递延所得税负债增加-44,874.53-450,233.28
  存货的减少--11,318,711.59--1,903,788.14
  经营性应收项目的减少--14,475,826.42--4,162,392.43
  经营性应付项目的增加-9,828,555.52--12,657,917.89
  其他-2,978,626.58-11,929,815.87
  现金的期末余额-98,665,009.83-64,125,887.58
  减:现金的期初余额-64,125,887.58-211,533,558.01
  现金及现金等价物的净增加额-34,539,122.25--147,407,670.43
公告日期2025-10-242025-08-272025-04-282025-04-28
审计意见(境内)标准无保留意见
TOP↑